Approval · Notice of Compliance 17081 · 2015
ELELYSO: Notice of Compliance 17081
Issued July 10, 2015
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 17081
- Date
- July 10, 2015
- Company
- Pfizer Canada UlcKirkland, Quebec, Canada
- Product type
- Biologic
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- New manufacturing site
- Therapeutic class
- Enzyme replacement therapy
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| ELELYSO | Not yet assigned | — |
Medicinal ingredients
- TALIGLUCERASE ALFA 200 UNIT per VIAL